• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Transient Ischemic Attack (2109); Restenosis (4576)
Event Date 04/21/2012
Event Type  Injury  
Manufacturer Narrative
Article title: factors affecting long-term restenosis after carotid stenting for carotid atherosclerotic disease neuroradiology (2012) 54:1347¿1353 doi 10.1007/s00234-012-1031-y.Average age, majority gender, date of publication.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A journal article was submitted detailing retrospective analysis of patients who underwent carotid artery stenting (cas) for carotid atherosclerotic disease.102 patients were included in the study with a total of 105 cas procedures performed.Medtronic¿s protégé carotid stent was amongst the devices implanted in the population.Approximately 92% of the stents used in the study were non-medtronic stents.Periprocedural complications included were stroke, 2.7 %, tia, 1.8 %; cardiac, 0.9 %; and others, 0.9 %), with permanent complications of 3.6 %.Restenosis was reported in 26.7% of cases, with 1.9% requiring endovascular intervention.The remainder were asymptomatic or managed with medical therapy.Two thirds of restenosis occurred within the first 8 months of the stenting, whereas in two of our patients, as late as 40 months from the initial stenting.Use of one identified non-medtronic stent was noted to be related to the prevalence of restenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key12331132
MDR Text Key266877171
Report Number2183870-2021-00294
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other
Type of Report Initial
Report Date 08/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/17/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received08/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-